Search Results

Italian biopharma Chiesi Farmaceutici SpA announced Sunday it was acquiring rare disease-focused Amryt Pharma in a deal that could reach up to $1.48 billion in value.

The global immune checkpoint inhibitors market size accounted for USD 37.31 billion in 2022 and is expected to attain around USD 148.1 billion by 2030 with a noteworthy CAGR of 18.81% from 2022 to 2030.

Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for patients in need of new treatment options, announces the receipt of a $1.48 million payment under its contract with the Cancer Prevention and Research Institute of Texas (CPRIT).

Applied Energetics, Inc. announced that it has been awarded a $1.148 million Phase II Small Business Technology Transfer contract by the U.S Army to continue the Company’s research, development and testing of an ultra-broadband infrared source capable of disrupting optical infrared sensors within the engagement time window, at tactically relevant ranges.